- Home
- MVO vs MODD Comparison
MVO vs MODD Comparison
Compare MVO & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$3.97
Company Overview
Basic Information| Metric | MVO | MODD |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 23.5M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | MVO | MODD |
|---|---|---|
| Price | $2.56 | $3.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 348.0K | 39.1K |
| Earning Date | 01-01-0001 | 02-17-2026 |
| Dividend Yield | ★ 17.46% | N/A |
| EPS Growth | N/A | ★ 34.62 |
| EPS | ★ 1.46 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.97 | $0.12 |
| 52 Week High | $6.26 | $6.16 |
Technical Indicators
Market Signals| Indicator | MVO | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 50.67 |
| Support Level | $2.16 | $0.41 |
| Resistance Level | $2.80 | $6.04 |
| Average True Range (ATR) | 0.22 | 0.51 |
| MACD | -0.03 | -0.27 |
| Stochastic Oscillator | 54.29 | 3.00 |
Price Performance
Historical Comparison MVO
MODD
About MVO MV Oil Trust Units of Beneficial Interests
MV Oil Trust is a statutory trust. The trust was created to acquire and hold the net profits interest for the benefit of the Trust unitholders.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.